全文获取类型
收费全文 | 2493863篇 |
免费 | 175550篇 |
国内免费 | 4736篇 |
专业分类
耳鼻咽喉 | 36979篇 |
儿科学 | 78950篇 |
妇产科学 | 72263篇 |
基础医学 | 356745篇 |
口腔科学 | 72957篇 |
临床医学 | 211278篇 |
内科学 | 483532篇 |
皮肤病学 | 54979篇 |
神经病学 | 198789篇 |
特种医学 | 99314篇 |
外国民族医学 | 799篇 |
外科学 | 387125篇 |
综合类 | 53770篇 |
现状与发展 | 7篇 |
一般理论 | 746篇 |
预防医学 | 177541篇 |
眼科学 | 59237篇 |
药学 | 189058篇 |
5篇 | |
中国医学 | 5292篇 |
肿瘤学 | 134783篇 |
出版年
2018年 | 23792篇 |
2016年 | 21185篇 |
2015年 | 24047篇 |
2014年 | 32637篇 |
2013年 | 49720篇 |
2012年 | 67098篇 |
2011年 | 70993篇 |
2010年 | 42056篇 |
2009年 | 39634篇 |
2008年 | 68465篇 |
2007年 | 74513篇 |
2006年 | 75348篇 |
2005年 | 73896篇 |
2004年 | 71290篇 |
2003年 | 69339篇 |
2002年 | 68271篇 |
2001年 | 112030篇 |
2000年 | 115097篇 |
1999年 | 97841篇 |
1998年 | 27229篇 |
1997年 | 24532篇 |
1996年 | 24022篇 |
1995年 | 22622篇 |
1994年 | 21413篇 |
1992年 | 76845篇 |
1991年 | 75074篇 |
1990年 | 73996篇 |
1989年 | 72133篇 |
1988年 | 67153篇 |
1987年 | 66010篇 |
1986年 | 63064篇 |
1985年 | 60074篇 |
1984年 | 45018篇 |
1983年 | 38611篇 |
1982年 | 23121篇 |
1981年 | 20780篇 |
1979年 | 43084篇 |
1978年 | 30589篇 |
1977年 | 26466篇 |
1976年 | 24475篇 |
1975年 | 27463篇 |
1974年 | 32490篇 |
1973年 | 31426篇 |
1972年 | 30142篇 |
1971年 | 28063篇 |
1970年 | 26327篇 |
1969年 | 25450篇 |
1968年 | 23946篇 |
1967年 | 21217篇 |
1966年 | 19818篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. 总被引:6,自引:1,他引:5
下载免费PDF全文
![点击此处可从《The Journal of clinical investigation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
H Chiao S Foster R Thomas J Lipton R A Star 《The Journal of clinical investigation》1996,97(9):2038-2044
Alpha-Melanocyte-stimulating hormone (MSH) is a potent anti-inflammatory agent in many models of inflammation, suggesting that it inhibits a critical step common to different forms of inflammation. We showed previously that alpha-MSH inhibits nitric oxide (NO) production in cultured macro-phages. To determine how alpha-MSH acts in vivo, we induced acute hepatic inflammation by administering endotoxin (LPS) to mice pretreated with Corynebacterium parvum, alpha-MSH prevented liver inflammation even when given 30 min after LPS administration. To determine the mechanisms of action of alpha-MSH, we tested its influence on NO, infiltrating inflammatory cells, cytokines, and chemokines. Alpha-MSH inhibited systemic NO production, hepatic neutrophil infiltration, and increased hepatic mRNA abundance for TNF alpha, and the neutrophil and monocyte chemokines (KC/IL-8 and MCP-1). We conclude that alpha-MSH prevents LPS-induced hepatic inflammation by inhibiting production of chemoattractant chemokines which then modulate infiltration of inflammatory cells. Thus, alpha-MSH has an effect very early in the inflammatory cascade. 相似文献
992.
993.
Introduction – Toxic phytanic acid concentrations in patients with Refsum's disease can be reduced by plasma separation, performed either as plasmapheresis, or as cascade filtration. The latter procedure is as efficient and safe as plasmapheresis, and eliminates the need for albumin replacement. This study investigates the loss of immunoglobulins associated with the procedure. Material and methods — Immunoglobulin- and phytanic acid serum concentrations before and after cascade filtration (n=16) were measured in a patient with Refsum's disease and their removal determined. Filters with sieving coefficients for immunoglobulin G of 70% and 30% were compared with each other and with historical data on plasmapheresis. Results — While differences in immunoglobulin M loss are negligible, the loss of immunoglobulin G in cascade filtration is significantly less than that reported for plasmapheresis and depends upon the pore size of the employed filters. The loss is least with larger pore size, but this advantage becomes statistically insignificant if immunoglobulin G loss is related to the lesser decrease in phytanic acid concentration that was achieved simultaneously in this study. Conclusion — Unless transplantation of a-hydroxylase containing tissue can be established as treatment for Refsum's disease, cascade filtration appears to be the treatment of choice in order to avoid loss of albumin and to reduce the loss of immunoglobulin G. 相似文献
994.
J. de Pedro-Cuesta V. Abraira G.-X. Jiang G. Solders S. Fredrikson 《Acta neurologica Scandinavica》1996,93(2-3):175-183
Using hierarchical cluster analysis, applied to 47 cases of Guillain-Barre Syndrome (GBS) incident in South-West Stockholm (SWS) during the period from January 1973 to June 1992, we identified three major clinicoepidemiological subgroups. The first subgroup, 25.5% of the cases (26.7 ± 6.7 years), recorded a peak incidence at ages 20–29 years and presented significant differences from other subgroups, a high proportion of cases with onset at low age preceded by respiratory infection (83.3%) and with normal motor conduction velocity (50.0%). Also found, were less affected biological parameters, a rapidly progressive course and independence in gait at one month after onset. A second subgroup, 27.7% of cases, was severely affected, clinically and functionally. It consisted predominantly of young individuals (22.7 ± 11.1 years), with a high incidence (69.2% of cases) in autumn. A third subgroup, comprising 40.47; of cases, was older (61.1 ± 11.0 years) and, in general, also severely affected. The incidence of this form appeared to be invariant with time. 相似文献
995.
996.
A. G. D. Maran J. A. Wilson M. N. Gaze 《European archives of oto-rhino-laryngology》1993,250(3):127-132
Summary Squamous cell carcinoma of the head and neck is a disease predominantly of males and is due to a variety of known environmental irritants, notably cigarette smoke. Dietary, viral and immunological factors may also be relevant. Head and neck squamous cancers express epidermal growth factor receptors and some show weak levels of oestrogen receptor activity, but a reliable serum marker of tumour burden remains to be identified. The prognosis is found to be less favourable in females, in those with advanced T stage, in association with multiple node involvement, especially where extracapsular spread is present and where the T4/T8 ratio is elevated. Administration of heterologous blood during therapy may also have an adverse effect on prognosis. Interested clinicians must remember that most cases are preventable.
Correspondence to: A.G.D. Maran 相似文献
997.
998.
T Oda N Yoshizawa S Oshima A Takeuchi T Kubota S Kondo Y Oshikawa Y Akashi Y Suzuki H Niwa 《Nihon Jinzo Gakkai shi》1990,32(6):631-641
To investigate the role of cell-mediated immunity (CMI) in glomerulonephritis (GN), we identified the infiltrating immune cells both within the glomerulus and in the interstitium. Frozen sections from 103 patients with various forms of GN: 10 with minor glomerular abnormality (MGA) as control, 10 with minimal change nephrotic syndrome (MCNS), 10 with membranous nephropathy (MN), 9 with focal glomerulosclerosis (FGS), 30 with IgA nephropathy (IgAN), 22 with acute post streptococcal glomerulonephritis (APSGN), and 2 with rapidly progressive glomerulonephritis (RPGN) were examined using monoclonal antibodies (MoAb) by indirect immunoalkaline-phosphatase labelling. In most glomerulonephritis, monocyte/M phi and helper/inducer T cells were predominantly infiltrating in the interstitium, but intraglomerular infiltration was rare, except for APSGN. This interstitial infiltration increased proportionally to the level of serum creatinine, and was most prominent in RPGN. Apparently different distribution was seen in APSGN, that is, prominent increase in total number of intra-glomerular monocyte/M phi infiltration with slightly increased T cells. The change was correlated with time after onset; namely the more leucocytic infiltration was observed when the tissue was taken earlier. These data suggest that in APSGN, monocyte/M phi accumulate in glomeruli via cell mediated immunity in addition to humoral immune mechanism resulting in glomerular hypercellularity, whereas in most chronic glomerulonephritis interstitial leucocyte infiltration, particularly helper T cells and monocyte/M phi may play an important role in the progression of glomerulonephritis. 相似文献
999.
1000.
CT- or sonography-guided biopsy of the liver in the presence of ascites: frequency of complications 总被引:1,自引:0,他引:1
F B Murphy K P Barefield H V Steinberg M E Bernardino 《AJR. American journal of roentgenology》1988,151(3):485-486
The presence of ascites has been considered a contraindication to percutaneous biopsy of the liver. To determine the validity of this assumption, we performed percutaneous biopsies of the liver under CT or sonographic guidance in 28 patients who had ascites and in 28 patients who did not have ascites and compared the complication rates in the two groups. Twenty-two patients (79%) in the group with ascites and 19 patients (68%) in the group without ascites had biopsies to determine the cause or extent of chronic liver disease. The remainder were oncologic patients who had biopsies to determine the cause of a focal hepatic mass. The complication rate in the patients who had ascites (32%) was less than that in the patients who did not have ascites (43%) (the difference did not reach statistical significance, p less than .30). In the ascites group, complications included transient hypotension (five patients), a mild-to-moderate fall in hematocrit (three patients), and a small leak of ascites from the biopsy site (one patient). In the control group, minor complications included transient hypotension (three patients), a mild-to-moderate fall in hematocrit (seven patients), and a small subcapsular hematoma (one patient). One major complication occurred in the control group: a patient required a blood transfusion because of the fall in his hematocrit. We conclude that the complication rate in liver biopsies guided by CT or sonography in the presence of ascites is not higher than similar biopsies done in the absence of ascites. Ascites should not be considered a contraindication for performing such biopsies. 相似文献